STOCK TITAN

Ameriprise (SYNA) discloses 18% Synaptics stake via Columbia Seligman fund

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Ameriprise Financial, Inc., through its investment adviser Columbia Management Investment Advisers and related funds, filed an amended Schedule 13G reporting significant ownership of Synaptics Incorporated common stock. As of December 31, 2025, Ameriprise is deemed to beneficially own 7,021,238 shares, or 18.0% of the class, primarily via Columbia-managed funds. The Columbia Seligman Technology and Information Fund separately reports beneficial ownership of 4,279,098 shares, representing 11.0% of the outstanding common stock. The filers state the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Synaptics.

Positive

  • None.

Negative

  • None.

Insights

Large institutional holders report up to 18% of Synaptics, with a passive intent statement.

Ameriprise Financial and its investment adviser report beneficial ownership of 7,021,238 Synaptics shares, or 18.0% of the common stock as of December 31, 2025. The Columbia Seligman Technology and Information Fund alone reports 4,279,098 shares, or 11.0%.

The filing clarifies that Columbia Management Investment Advisers may be deemed to beneficially own shares held across various funds and accounts, and Ameriprise may be deemed to own those held by Columbia. Each entity disclaims beneficial ownership, signalling that legal control and economic exposure are structured through advisory relationships.

The certification states the securities were acquired and are held in the ordinary course of business and not to change or influence control of Synaptics. Future ownership levels will depend on portfolio decisions within Columbia-managed funds and accounts, but this document presents the position as a passive institutional holding at year-end 2025.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Ameriprise Financial, Inc.
Signature:/s/ Michael G. Clarke
Name/Title:Michael G. Clarke, Senior Vice President, North America Head of Operations & Investor Services
Date:02/17/2026
Columbia Management Investment Advisers, LLC
Signature:/s/ Michael G. Clarke
Name/Title:Michael G. Clarke, Senior Vice President, North America Head of Operations & Investor Services
Date:02/17/2026
Columbia Seligman Technology and Information Fund
Signature:/s/ Michael G. Clarke
Name/Title:Michael G. Clarke, Senior Vice President & Chief Financial Officer
Date:02/17/2026

Comments accompanying signature: Contact Information Charles Chiesa VP Fund Treasurer Global Operations and Investor Services Telephone: 617-385-9593
Exhibit Information

Exhibit Index Exhibit I Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company. Exhibit II Joint Filing Agreement

FAQ

How much of Synaptics (SYNA) does Ameriprise Financial beneficially own?

Ameriprise Financial is deemed to beneficially own 7,021,238 Synaptics common shares, representing 18.0% of the class as of December 31, 2025. This ownership is largely through Columbia Management Investment Advisers and its managed funds and accounts, rather than direct share ownership by Ameriprise itself.

What stake does Columbia Seligman Technology and Information Fund hold in Synaptics (SYNA)?

Columbia Seligman Technology and Information Fund beneficially owns 4,279,098 Synaptics common shares, equal to 11.0% of the outstanding class as of December 31, 2025. These shares contribute to the broader position reported by Columbia Management Investment Advisers and Ameriprise Financial on the Schedule 13G/A.

Is Ameriprise’s Synaptics (SYNA) position intended to influence control of the company?

The filing states the Synaptics shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. It also notes the holdings are not in connection with any transaction intended to influence control, other than activities tied to specific nomination rules.

Which entities are reporting beneficial ownership of Synaptics (SYNA) in this Schedule 13G/A?

Three reporting persons disclose beneficial ownership: Ameriprise Financial, Inc., Columbia Management Investment Advisers, LLC, and the Columbia Seligman Technology and Information Fund. Ameriprise is the parent holding company of Columbia, which advises the fund and other managed investment vehicles holding Synaptics shares.

Do other Columbia-managed funds besides the Seligman Fund own Synaptics (SYNA) shares?

Yes. The filing notes additional Synaptics shares reported by Columbia Management Investment Advisers are held by various other funds or accounts it manages. Each such fund or account receives dividends and may direct sale proceeds, but none individually holds more than 5% of Synaptics as of December 31, 2025.

What voting and dispositive powers do the reporting persons have over Synaptics (SYNA) shares?

Ameriprise reports 6,557,266 Synaptics shares with shared voting power and 7,021,238 shares with shared dispositive power, with no sole power reported. The Columbia Seligman Technology and Information Fund reports sole voting power over 4,279,098 shares and shared dispositive power over the same amount.